mRNA transfected dendritic cell vaccine (GemVax)

N/A

Report date: 2022/11/27 13:48:35

Base Information

Drug NamemRNA transfected dendritic cell vaccine (GemVax)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsProstatic NeoplasmsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGemvax As

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGemvax As

Active IndicationsN/A

Inactive IndicationsProstatic NeoplasmsMelanoma

Other Information

ATC CodeN/A